173 related articles for article (PubMed ID: 35892859)
21. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression.
Ma X; Qi S; Duan Z; Liao H; Yang B; Wang W; Tan J; Li Q; Xia X
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28963737
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
25. Long Non-coding RNA
Lv L; He L; Chen S; Yu Y; Che G; Tao X; Wang S; Jian Z; Zhang X
Front Oncol; 2019; 9():1383. PubMed ID: 31921641
[TBL] [Abstract][Full Text] [Related]
26. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer.
Guo T; Yuan X; Liu DF; Peng SH; Xu AM
Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419
[TBL] [Abstract][Full Text] [Related]
27. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
28. microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.
Wang SH; Li X; Zhou LS; Cao ZW; Shi C; Zhou CZ; Wen YG; Shen Y; Li JK
Tumour Biol; 2013 Dec; 34(6):3705-12. PubMed ID: 23873106
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast Carcinoma.
Pattanayak B; Garrido-Cano I; Adam-Artigues A; Tormo E; Pineda B; Cabello P; Alonso E; Bermejo B; Hernando C; Martínez MT; Rovira A; Albanell J; Rojo F; Burgués O; Cejalvo JM; Lluch A; Eroles P
Front Oncol; 2020; 10():1661. PubMed ID: 33014831
[TBL] [Abstract][Full Text] [Related]
30. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.
Chen X; Wang YW; Gao P
J Exp Clin Cancer Res; 2018 May; 37(1):100. PubMed ID: 29743122
[TBL] [Abstract][Full Text] [Related]
31. Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis.
Chang L; Zhou R
J Bone Miner Metab; 2022 Mar; 40(2):262-274. PubMed ID: 35083555
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-148a-3p Directly Targets SERPINE1 to Suppress EMT-Mediated Colon Adenocarcinoma Progression.
Hu B; Chen Z; Wang X; Chen F; Song Z; Cao C
Cancer Manag Res; 2021; 13():6349-6362. PubMed ID: 34408494
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
34. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
Su H; Fan G; Huang J; Qiu X
Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
[TBL] [Abstract][Full Text] [Related]
35. CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760.
Yuan J; Liu Y; Zhang Q; Ren Z; Li G; Tian R
Cancer Manag Res; 2021; 13():4433-4445. PubMed ID: 34103997
[TBL] [Abstract][Full Text] [Related]
36. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
37. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.
Hu XT; Xing W; Zhao RS; Tan Y; Wu XF; Ao LQ; Li Z; Yao MW; Yuan M; Guo W; Li SZ; Yu J; Ao X; Xu X
J Exp Clin Cancer Res; 2020 Dec; 39(1):270. PubMed ID: 33267897
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of miR-489-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting Histone Deacetylase 2 (HDAC2).
Jia T; Wang M; Yan W; Wu W; Shen R
Neuroscience; 2022 Feb; 484():16-25. PubMed ID: 34914969
[TBL] [Abstract][Full Text] [Related]
39. Metal-Regulatory Transcription Factor-1 Targeted by miR-148a-3p Is Implicated in Human Hepatocellular Carcinoma Progression.
Lyu Z; Yang M; Yang T; Ma M; Yang Z
Front Oncol; 2021; 11():700649. PubMed ID: 34660270
[TBL] [Abstract][Full Text] [Related]
40. LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells.
Li Y; Li H; Wang W; Yu X; Xu Q
Mol Cell Probes; 2020 Dec; 54():101667. PubMed ID: 32946972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
